AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.06-3.86 (-0.95%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.06-3.86 (-0.95%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|
21.4 C
New York
Monday, October 26, 2026

Tag: report

newsFORsourcecompanycontentinformation1releasesmarket

Finance Complaint List Launches Comprehensive Fraud Recovery Platform to Combat Online Stock-Trading

Manchester, England, June 25, 2026 (GLOBE NEWSWIRE) -- In direct response to the increasingly sophisticated and predatory tactics utilized by global cybercriminals, the Finance Complaint List has officially announced the launch of its newly integrated financial protection and recovery ecosystem. This comprehensive platform introduces an advanced, privacy-first global fraud reporting database alongside specialized asset recovery pathways. The unified framework is designed to safeguard traditional investments and personal savings, offering an unprecedented end-to-end defense mechanism for retail investors and everyday consumers alike.

Polymethyl Methacrylate (PMMA) Market worth $6.48 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 25, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Polymethyl Methacrylate (PMMA) Market by Grade (General-Purpose, Optical), Form (Extruded Sheet, Cast Acrylic Sheet),...

THCA Pre-Rolls 2026: Exhale Wellness Reports Rising Demand for Ready-to-Smoke Hemp Pre-Rolls as Buyers Move Away From Loose Flower

Exhale Wellness 2026 survey: 70% of THCA pre-roll buyers cite convenience as shoppers move from loose flower to lab-tested, ready-to-smoke hemp pre-rolls.

European Commission report supports cBrain’s expansion of environmental permitting activities in Europe

European Commission identifies the cBrain F2® platform as a leading European example of digital environmental permitting

Colt DCS Reports 27% Reduction in Greenhouse Gas Emissions

Delivered 27% reduction in greenhouse gas emissions in Scope 1, 2 (market based) and 3 compared to 2019 base yearAchieved 100% renewable electricity in...

DEMIRE is expanding its ESG database to cover almost its entire portfolio and is continuing to drive forward decarbonization

DEMIRE is expanding its ESG database to cover almost its entire portfolio and is continuing to drive forward decarbonization

Global Times: Xi calls for solid measures to modernize agriculture, rural areas

BEIJING, June 25, 2026 /PRNewswire/ -- Chinese President Xi Jinping has called for solid measures to advance the modernization of agriculture and rural areas,...

Digital Health Market Size to Reach USD 1,830.4 Billion by 2033, Driven by Rising Adoption of Telehealth, mHealth, AI-Based Solutions, and Connected Healthcare Technologies:...

SAN FRANCISCO, June 24, 2026 /PRNewswire/ -- The global digital health market is expected to witness significant expansion over the coming years, with the...

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

[Latest] Global Therapeutic Apheresis Market Size/Share Worth USD 8.94 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast,...

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Therapeutic Apheresis Market size & share revenue was valued at approximately USD 3.84 Billion in 2025 and is expected to reach USD 4.18 Billion in 2026 and is expected to reach around USD 8.94 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Terumo BCT Inc., Fresenius Kabi AG, Haemonetics Corporation, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., Miltenyi Biotec GmbH, Nikkiso Co. Ltd., Kaneka Corporation, Mallinckrodt Pharmaceuticals (Uvadex/ECP), Photomedex Inc., Macopharma SAS and others. 
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Therapeutic Apheresis Market size & share revenue was valued at approximately USD 3.84 Billion in 2025 and is expected to reach USD 4.18 Billion in 2026 and is expected to reach around USD 8.94 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Terumo BCT Inc., Fresenius Kabi AG, Haemonetics Corporation, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., Miltenyi Biotec GmbH, Nikkiso Co. Ltd., Kaneka Corporation, Mallinckrodt Pharmaceuticals (Uvadex/ECP), Photomedex Inc., Macopharma SAS and others.

Jamieson Wellness Responds to Media Report

TORONTO, June 24, 2026 /CNW/ - Jamieson Wellness Inc. ("Jamieson" or the "Company") (TSX: JWEL) acknowledges a recent media report regarding a potential sale...

Cardinal Infrastructure Group Announces Pricing of Upsized Public Offering

RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (Nasdaq: CDNL) today announced the pricing of an upsized...

Cold Chain Packaging Market Size to Reach USD 93.1 Billion by 2033, Driven by Biopharmaceutical Expansion, E-commerce Growth, and Rising Demand for Temperature-Sensitive Logistics

Global market projected to grow at a CAGR of 13.5% from 2026 to 2033 as pharmaceutical, food, and healthcare industries increasingly rely on advanced...

Silvercorp Announces Filing of Updated Technical Reports

Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, June 24, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) announces...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReport

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers